Tay Sachs is a devastating genetic disease with no known cure. But now, experts are hoping a new push for awareness could help parents down the road.

The Global Tay-Sachs Disease Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 4.08 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2025 to ...

Patients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 gangliosidosis, which includes Tay-Sachs and Sandhoff diseases, exhibited a ...